Page 102 - Read Online

Mueller et al. Vessel Plus 2018;2:13 I http://dx.doi.org/10.20517/2574-1209.2018.19 Page 9 of 10

analysis. Stroke 2009;40:3711-7.
12. Markus HS, King A, Shipley M, Topakian R, Cullinane M, Reihill S, Bornstein NM, Schaafsma A. Asymptomatic embolisation
for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol
2010;9:663-71.
13. Müller HF, Viaccoz A, Fisch L, Bonvin C, Lovblad KO, Ratib O, Lalive P, Pagano S, Vuilleumier N, Willi JP, Sztajzel R.
18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals. Stroke
2014;45:3561-6.
14. Naylor AR, Rothwell PM, Bell PR. Overview of the principal results and secondary analyses from the European and North American
randomised trials of endarterectomy for symptomatic carotid stenosis. Eur J Vasc Endovasc Surg 2003;26:115-29.
15. Ringelstein RB, Droste DW, Babikian VI, Evans DH, Grosset DG, Kaps M, Markus HS, Russell D, Siebler M. Consensus on
microembolus detection by TCD: international consensus group on microembolus detection. Stroke 1998;29:725-9.
16. Choi Y, Saqqur M, Asil T, Jin A, Stewart E, Stephenson C, Ibrahim M, Roy J, Boulanger JM, Coutts S, Khan F, Demchuk AM. A
combined power M-mode and single gate transcranial doppler ultrasound microemboli signal criteria for improving emboli detection
and reliability. J Neuroimaging 2010;20:359-67.
17. Koutouzis M, Rallidis LS, Peros G. Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease. Acta Neurol Scand
2009;119:119-25.
18. Papas TT, Maltezos CK, Papanas N. High-sensitivity CRP is correlated with neurologic symptoms and plaque instability in patients
with severe stenosis of the carotid bifurcation. Vase Endovascular Surg 2008;42:249-55.
19. Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, Sacco RL. High-sensitivity C-reactive protein predicts mortality but
not stroke: the Northern Manhattan Study. Neurology 2009;73:1300-7.
20. Avgerinos ED, Kadoglou NP, Moulakakis KG, Giannakopoulos TG, Liapis CD. Current role of biomarkers in carotid disease: a systematic
review. Int J Stroke 2011;6:337-45.
21. Heider P, Poppert H, Wolf O, Liebig T, Pelisek J, Schuster T, Eckstein HH. Fibrinogen and high-sensitive C-reactive protein as serologic
predictors for perioperative cerebral microembolic lesions after carotid endarterectomy. J Vasc Surg 2007;46:449-54.
22. Versaci F, Reimers B, Prati F, Gaspardone A, Del Giudice C, Pacchioni A, Mauriello A, Cortese C, Nardi P, De Fazio A, Chiariello GA,
Proietti I, Chiariello L. Prediction of cardiovascular events by inflammatory markers in patients undergoing carotid stenting. Mayo Clin
Proc 2012;87:50-8.
23. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JH, Tawakol A, Farkouh ME, Fayad ZA.
Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. JACC
Cardiovasc Imaging 2013;6:1087-94.
24. Mani V, Woodward M, Samber D, Bucerius J, Tawakol A, Kallend D, Rudd JH, Abt M, Fayad ZA. Predictors of change in carotid
atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study. Int J
Cardiovasc Imaging 2014;30:571-82.
25. Barlic J, Murphy PM. Chemokine regulation of atherosclerosis. J Leukoc Biol 2007;82:226-36.
26. von Hundelshausen P, Weber KSC, Huo Y, Proudfoot AE, Nelson PJ, Ley K, Weber C. RANTES deposition by platelets triggers
monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001;103:1772-7.
27. Zaremba J, Ilkowski J, Losy J. Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute
ischaemic stroke. Folia Neuropathol 2006;44:282-9.
28. Ammirati E, Moroni F, Norata GD, Magnoni M, Camici PG. Markers of inflammation associated with plaque progression and instability
in patients with carotid atherosclerosis. Mediators Inflamm 2015:2015:718329.
29. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1,
ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities
(ARIC) study. Circulation 1997;96:4219-25.
30. Weinkauf CC, Concha-Moore K, Lindner JR, Marinelli ER, Hadinger KP, Bhattacharjee S, Berman SS, Goshima K, Leon LR Jr,
Matsunaga TO, Unger E. Endothelial vascular cell adhesion molecule 1 is a marker for high-risk carotid plaques and target for
ultrasound molecular imaging. J Vasc Surg 2018; doi: 10.1016/j.jvs.2017.10.088.
31. Palenkić H, Bačun T, Ćosić A, Lovričević I, DeSyo D, Drenjančević I. Serum levels of ICAM-1, VCAM-1 and E-selectin in early
postoperative period and three months after eversion carotid endarterectomy. Med Glas (Zenica) 2014;11:313-9.
32. Yin R, Ma A, Pan X, Yang S. Biomarkers of cerebral microembolic signals. Clin Chim Acta 2017;475:164-8.
33. Ma A, Yang S, Wang Y, Wang X, Pan X. Increase of serum CXCL16 level correlates well to microembolic signals in acute stroke
patients with carotid artery stenosis. Clin Chim Acta 2016;460:67-71.
34. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res
2002;90:251-62.
35. Ramos-Fernandez M, Bellolio MF, Stead LG. Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
J Stroke Cerebrovasc Dis 2011;20:47-54.
36. Loftus IM, Naylor AR, Bell PR, Thompson MM. Plasma MMP-9 - a marker of carotid plaque instability. Eur J Vasc Endovasc Surg
2001;21:17-21.
37. Johnson JL, Jenkins NP, Huang WC, Di Gregoli K, Sala-Newby GB, Scholtes VP, Moll FL, Pasterkamp G, Newby AC. Relationship
of MMP-14 and TIMP-3 expression with macrophage activation and human atherosclerotic plaque vulnerability. Mediators Inflamm
2014;2014:276457.